IL298520A - Treatment of alopecia areata - Google Patents

Treatment of alopecia areata

Info

Publication number
IL298520A
IL298520A IL298520A IL29852022A IL298520A IL 298520 A IL298520 A IL 298520A IL 298520 A IL298520 A IL 298520A IL 29852022 A IL29852022 A IL 29852022A IL 298520 A IL298520 A IL 298520A
Authority
IL
Israel
Prior art keywords
compound
oxopropanenitrile
octan
pyrrolo
pyrimidin
Prior art date
Application number
IL298520A
Other languages
English (en)
Hebrew (he)
Original Assignee
Leo Pharma As
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2015190849A external-priority patent/JP2017066061A/ja
Application filed by Leo Pharma As, Japan Tobacco Inc filed Critical Leo Pharma As
Publication of IL298520A publication Critical patent/IL298520A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL298520A 2015-09-24 2016-09-22 Treatment of alopecia areata IL298520A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15186644 2015-09-24
JP2015190849A JP2017066061A (ja) 2015-09-29 2015-09-29 円形脱毛症治療剤
PCT/EP2016/072531 WO2017050891A1 (en) 2015-09-24 2016-09-22 Treatment of alopecia areata

Publications (1)

Publication Number Publication Date
IL298520A true IL298520A (en) 2023-01-01

Family

ID=57047187

Family Applications (3)

Application Number Title Priority Date Filing Date
IL298520A IL298520A (en) 2015-09-24 2016-09-22 Treatment of alopecia areata
IL312861A IL312861A (en) 2015-09-24 2016-09-22 Treatment of regional baldness
IL257918A IL257918A (en) 2015-09-24 2018-03-06 Treatment of regional baldness

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL312861A IL312861A (en) 2015-09-24 2016-09-22 Treatment of regional baldness
IL257918A IL257918A (en) 2015-09-24 2018-03-06 Treatment of regional baldness

Country Status (27)

Country Link
US (3) US20180263986A1 (https=)
EP (1) EP3352734B1 (https=)
JP (1) JP6776345B2 (https=)
KR (1) KR102728341B1 (https=)
CN (1) CN108135834B (https=)
AU (3) AU2016325388A1 (https=)
BR (1) BR112018005771B1 (https=)
CA (1) CA2998972A1 (https=)
CY (1) CY1122837T1 (https=)
DK (1) DK3352734T3 (https=)
ES (1) ES2779762T3 (https=)
HR (1) HRP20200472T1 (https=)
HU (1) HUE049052T2 (https=)
IL (3) IL298520A (https=)
LT (1) LT3352734T (https=)
MX (1) MX375024B (https=)
MY (1) MY196541A (https=)
PL (1) PL3352734T3 (https=)
PT (1) PT3352734T (https=)
RS (1) RS60365B1 (https=)
RU (1) RU2754997C2 (https=)
SG (1) SG10202111361TA (https=)
SI (1) SI3352734T1 (https=)
TW (1) TWI720022B (https=)
UA (1) UA124192C2 (https=)
WO (1) WO2017050891A1 (https=)
ZA (1) ZA201801722B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
WO2023029943A1 (zh) * 2021-09-03 2023-03-09 星药科技(北京)有限公司 一种芳杂环化合物及其制备方法和用途
JP2025514747A (ja) 2022-04-20 2025-05-09 レオ ファーマ アクティーゼルスカブ 前頭部線維性脱毛症の治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent
KR102306276B1 (ko) * 2013-10-21 2021-09-30 니뽄 다바코 산교 가부시키가이샤 안질환의 치료제 또는 예방제

Also Published As

Publication number Publication date
EP3352734A1 (en) 2018-08-01
CY1122837T1 (el) 2021-05-05
HK1257770A1 (en) 2019-10-25
CN108135834B (zh) 2021-07-27
DK3352734T3 (da) 2020-03-30
TW201717955A (zh) 2017-06-01
JP6776345B2 (ja) 2020-10-28
AU2022202508A1 (en) 2022-05-12
SI3352734T1 (sl) 2020-07-31
RU2018114922A (ru) 2019-10-28
BR112018005771B1 (pt) 2023-12-05
HUE049052T2 (hu) 2020-09-28
KR102728341B1 (ko) 2024-11-11
US20220088020A1 (en) 2022-03-24
RS60365B1 (sr) 2020-07-31
EP3352734B1 (en) 2020-01-15
LT3352734T (lt) 2020-04-10
HRP20200472T1 (hr) 2020-09-18
US20180263986A1 (en) 2018-09-20
RU2754997C2 (ru) 2021-09-08
RU2018114922A3 (https=) 2019-12-11
MY196541A (en) 2023-04-19
WO2017050891A1 (en) 2017-03-30
SG10202111361TA (en) 2021-12-30
UA124192C2 (uk) 2021-08-04
KR20180054767A (ko) 2018-05-24
IL312861A (en) 2024-07-01
MX2018003332A (es) 2018-08-16
IL257918A (en) 2018-05-31
CN108135834A (zh) 2018-06-08
ES2779762T3 (es) 2020-08-19
NZ740690A (en) 2024-11-29
TWI720022B (zh) 2021-03-01
MX375024B (es) 2025-03-06
AU2016325388A1 (en) 2018-03-29
BR112018005771A2 (pt) 2018-10-09
ZA201801722B (en) 2025-06-25
AU2024204716A1 (en) 2024-07-25
CA2998972A1 (en) 2017-03-30
PL3352734T3 (pl) 2020-08-24
US20240398809A1 (en) 2024-12-05
PT3352734T (pt) 2020-03-31
JP2018528238A (ja) 2018-09-27

Similar Documents

Publication Publication Date Title
US20240398809A1 (en) Treatment of alopecia areata
UA100119C2 (uk) Застосування 3-альфа-андростандіолу в поєднанні з агоністом 5-ht1а для лікування сексуальної дисфункції
US20230138114A1 (en) Treatment of hand eczema
AU2021388141A1 (en) Treatment of raynaud's disease
WO2023202989A1 (en) Treatment of frontal fibrosing alopecia
US20220395472A1 (en) Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis
JP2017519034A (ja) 手足症候群及び前記症候群に随伴する症候を治療する方法
HK1257770B (en) Treatment of alopecia areata
WO2025085050A1 (en) Treatment of frontal fibrosing alopecia
EP4665725A2 (en) Methods of treating solid tumors with mitogen activated protein kinase (mapk) pathway alterations